1. Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin.
- Author
-
Weber P, Ferber P, Fischer R, Winterhalter KH, and Vaughan L
- Subjects
- Animals, Antibodies, Monoclonal, Binding Sites, Chick Embryo, Contactins, Dermatan Sulfate pharmacology, Extracellular Matrix metabolism, Fibronectins chemistry, Glycosaminoglycans pharmacology, Heparitin Sulfate pharmacology, Membrane Glycoproteins metabolism, Protein Binding drug effects, Recombinant Fusion Proteins metabolism, Tenascin chemistry, Cell Adhesion Molecules, Neuronal, Fibronectins metabolism, Heparin pharmacology, Nerve Tissue Proteins metabolism, Neural Cell Adhesion Molecules metabolism, Tenascin metabolism
- Abstract
The structural basis for the interaction between tenascin-C and the neuronal cell adhesion molecule, contactin/F11, was investigated using plasmon surface resonance technology. The binding site on tenascin-C for contactin/F11 is shown to span the two fibronectin type III homology domains 5 and 6. Either domain alone is insufficient for binding. Heparin, heparan sulfate and dermatan sulfate inhibit this interaction through binding to a conserved heparin-binding site on domain 5. In contrast, chondroitin sulfates A and C have no such effect.
- Published
- 1996
- Full Text
- View/download PDF